TY  - JOUR
AU  - Kristensen, Anna Meta Dyrvig
AU  - Bovin, Ann
AU  - Zwisler, Ann Dorthe
AU  - Cerquira, Charlotte
AU  - Torp-Pedersen, Christian
AU  - Bøtker, Hans Erik
AU  - Gustafsson, Ida
AU  - Veien, Karsten Tange
AU  - Thomsen, Kristian Korsgaard
AU  - Olsen, Michael Hecht
AU  - Larsen, Mogens Lytken
AU  - Nielsen, Olav Wendelboe
AU  - Hildebrandt, Per
AU  - Foghmar, Sussie
AU  - Jensen, Svend Eggert
AU  - Lange, Theis
AU  - Sehested, Thomas
AU  - Jernberg, Tomas
AU  - Atar, Dan
AU  - Ibáñez, Borja
AU  - Prescott, Eva
PY  - 2020
DO  - 10.1186/s13063-020-4214-6
UR  - http://hdl.handle.net/20.500.12105/10356
AB  - Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling patients...
LA  - eng
PB  - BioMed Central (BMC)
TI  - Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
TY  - journal article
ER  -